- ICH GCP
- US Clinical Trials Registry
- Clinical Trial NCT02163785
Abdominoperineal Extra-Elevators Rectal Resection for Cancer: Prone Position vs. Supine Position (APPRO)
September 25, 2021 updated by: Matteo Frasson, Hospital Universitario La Fe
Estudio A.P.PRO: Estrategia quirúrgica en la amputación Abdominoperineal cilíndrica Del Recto Por cáncer: posición de litotomía vs. Prono-navaja
Prospective multicenter randomized controlled trial comparing the prone vs. the supine position of the perineal time of the Miles operation in patients with advanced rectal cancer.
Primary objective:
- Pathological circumferential resection margin
Secondary objectives:
- 5 year oncological outcomes
- Morbimortality rates
- Surgical specimen quality
- Perineal hernia incidence
Study Overview
Status
Terminated
Conditions
Intervention / Treatment
Study Type
Interventional
Enrollment (Actual)
280
Phase
- Not Applicable
Contacts and Locations
This section provides the contact details for those conducting the study, and information on where this study is being conducted.
Study Locations
-
-
-
Murcia, Spain
- Hospital Universitario "Virgen de la Arrixaca"
-
Valencia, Spain, 46026
- Hospital Universitario y Politécnico La Fe
-
Valencia, Spain
- Hospital Arnau de Vilanova
-
Valencia, Spain
- Hospital Clinico Universitario
-
-
Andalucia
-
Jerez, Andalucia, Spain
- Hospital del SAS
-
-
Andalucía
-
Cordoba, Andalucía, Spain
- Hospital Universitario Reina Sofia
-
-
Castilla Y Leon
-
Medina del Campo, Castilla Y Leon, Spain
- Hospital General
-
-
Cataluña
-
Barcelona, Cataluña, Spain
- Hospital Bellvitge
-
Barcelona, Cataluña, Spain
- Hospital del Mar
-
Girona, Cataluña, Spain
- Hospital Universitario Josep Trueta
-
Sabadell, Cataluña, Spain
- Hospital Universitario Parc Tauli
-
-
Galicia
-
Orense, Galicia, Spain
- Complexo Hospitalario Universitario
-
Vigo, Galicia, Spain
- Complejo Hospitalario Universitario
-
-
Navarra
-
Pamplona, Navarra, Spain
- Complejo Hospitalario
-
-
Pais Vasco
-
Donostia, Pais Vasco, Spain
- Hospital Universitario Donostia
-
-
Valencia
-
Elche, Valencia, Spain
- Hospital General Universitario
-
Requena, Valencia, Spain
- Hospital General
-
Sagunto, Valencia, Spain
- Hospital de Sagunto
-
Xativa, Valencia, Spain
- Hospital Luis Alcanyis
-
-
Participation Criteria
Researchers look for people who fit a certain description, called eligibility criteria. Some examples of these criteria are a person's general health condition or prior treatments.
Eligibility Criteria
Ages Eligible for Study
18 years and older (ADULT, OLDER_ADULT)
Accepts Healthy Volunteers
No
Genders Eligible for Study
All
Description
Inclusion Criteria:
- Patients with primary low lying rectal cancer involving or threatening anal sphincter complex as seen in MRI
Exclusion Criteria:
- American Society of Anaesthesiologists classification of Physical Health (ASA) IV patients
- Locally palliative purpose of the operation
- Age < 18 years
- Preoperative indication for pelvic exenteration
- Pregnancy
- Lack of patients consent
Study Plan
This section provides details of the study plan, including how the study is designed and what the study is measuring.
How is the study designed?
Design Details
- Primary Purpose: TREATMENT
- Allocation: RANDOMIZED
- Interventional Model: PARALLEL
- Masking: DOUBLE
Arms and Interventions
Participant Group / Arm |
Intervention / Treatment |
---|---|
ACTIVE_COMPARATOR: Supine position
Abdominoperineal resection - perineal time- in supine position
|
Abdominoperineal extra-elevators rectal resection for low lying rectal cancer involving anal sphincter complex
Other Names:
|
EXPERIMENTAL: Prone position
Abdominoperineal resection - perineal time- in prone position
|
Abdominoperineal extra-elevators rectal resection for low lying rectal cancer involving anal sphincter complex
Other Names:
|
What is the study measuring?
Primary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Assessment of the circumferential resection margin
Time Frame: 15-30 days after surgery date
|
Histopathological report of the circumferential resection margin of the surgical specimen obtained in patients that underwent perineal time of Miles procedure in prone vs supine position.
|
15-30 days after surgery date
|
Secondary Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Histopathological quality of surgical specimen
Time Frame: 15-30 days after
|
Comparison of the quality of the surgical specimen in terms of integrity of the circumferential resection margin, accidental iatrogenic rupture etc.
|
15-30 days after
|
Other Outcome Measures
Outcome Measure |
Measure Description |
Time Frame |
---|---|---|
Oncological outcomes
Time Frame: 5 years
|
Compare the incidence of local oncological disease, distance metastasis and survival in a 5 year follow up time span.
|
5 years
|
Morbidity of the perineal incision.
Time Frame: 1 day, 60 days ,1 ,2,3,4 and 5 years after surgery
|
Evaluation the clinical outcome of the perineal wound in terms of infection, dehiscence, perineal hernia etc.
|
1 day, 60 days ,1 ,2,3,4 and 5 years after surgery
|
Collaborators and Investigators
This is where you will find people and organizations involved with this study.
Sponsor
Investigators
- Principal Investigator: Matteo Frasson, MD, PhD, Hospital Universitario y Politécnico La Fe
- Study Chair: Eduardo Garcia-Granero, MD, PhD, EBSQ-c, Hospital Universitario y Politécnico La Fe
Publications and helpful links
The person responsible for entering information about the study voluntarily provides these publications. These may be about anything related to the study.
General Publications
- Garcia-Granero E, Faiz O, Munoz E, Flor B, Navarro S, Faus C, Garcia-Botello SA, Lledo S, Cervantes A. Macroscopic assessment of mesorectal excision in rectal cancer: a useful tool for improving quality control in a multidisciplinary team. Cancer. 2009 Aug 1;115(15):3400-11. doi: 10.1002/cncr.24387.
- Heald RJ, Moran BJ, Ryall RD, Sexton R, MacFarlane JK. Rectal cancer: the Basingstoke experience of total mesorectal excision, 1978-1997. Arch Surg. 1998 Aug;133(8):894-9. doi: 10.1001/archsurg.133.8.894.
- Flor-Lorente B, Frasson M, Montilla E. Extralevator abdominoperineal resection in the prone position. Cir Esp. 2014 Mar;92 Suppl 1:30-9. doi: 10.1016/S0009-739X(14)70006-5. English, Spanish.
- Frasson M, Garcia-Granero E. Reply to Kelly et al. Colorectal Dis. 2016 Mar;18(3):312-3. doi: 10.1111/codi.13272. No abstract available.
Study record dates
These dates track the progress of study record and summary results submissions to ClinicalTrials.gov. Study records and reported results are reviewed by the National Library of Medicine (NLM) to make sure they meet specific quality control standards before being posted on the public website.
Study Major Dates
Study Start
June 1, 2014
Primary Completion (ACTUAL)
January 1, 2021
Study Completion (ACTUAL)
January 1, 2021
Study Registration Dates
First Submitted
June 12, 2014
First Submitted That Met QC Criteria
June 13, 2014
First Posted (ESTIMATE)
June 16, 2014
Study Record Updates
Last Update Posted (ACTUAL)
October 1, 2021
Last Update Submitted That Met QC Criteria
September 25, 2021
Last Verified
September 1, 2021
More Information
Terms related to this study
Keywords
Additional Relevant MeSH Terms
Other Study ID Numbers
- APPRO
This information was retrieved directly from the website clinicaltrials.gov without any changes. If you have any requests to change, remove or update your study details, please contact register@clinicaltrials.gov. As soon as a change is implemented on clinicaltrials.gov, this will be updated automatically on our website as well.
Clinical Trials on Rectal Cancer
-
Ohio State University Comprehensive Cancer CenterNovartis Pharmaceuticals; National Comprehensive Cancer NetworkCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Recurrent Rectal CancerUnited States
-
M.D. Anderson Cancer CenterRecruitingEvaluation of Quality of Life and Utilities Following Surgical Treatment of Stage I-IV Rectal CancerStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Stage IV Rectal Cancer AJCC v8 | Stage IVA Rectal Cancer AJCC v8 | Stage IVB Rectal Cancer AJCC v8 | Stage IVC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage... and other conditionsUnited States
-
OHSU Knight Cancer InstituteNatera, Inc.RecruitingEstablishing a ctDNA Biomarker to Improve Organ Preserving Strategies in Patients With Rectal CancerStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8United States
-
M.D. Anderson Cancer CenterNational Cancer Institute (NCI)RecruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8United States
-
Roswell Park Cancer InstituteNational Cancer Institute (NCI)WithdrawnStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Rectal AdenocarcinomaUnited States
-
OHSU Knight Cancer InstituteOregon Health and Science University; Taiho Pharmaceutical Co., Ltd.RecruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8United States
-
Jonsson Comprehensive Cancer CenterNatera, Inc.; The Joseph Drown FoundationRecruitingStage III Rectal Cancer AJCC v8 | Stage IIIA Rectal Cancer AJCC v8 | Stage IIIB Rectal Cancer AJCC v8 | Stage IIIC Rectal Cancer AJCC v8 | Rectal Adenocarcinoma | Stage IIA Rectal Cancer AJCC v8 | Stage IIB Rectal Cancer AJCC v8 | Stage II Rectal Cancer AJCC v8 | Stage IIC Rectal Cancer AJCC v8 | Locally...United States
-
Case Comprehensive Cancer CenterCompletedStage IIA Rectal Cancer | Stage IIB Rectal Cancer | Stage IIC Rectal Cancer | Stage IIIA Rectal Cancer | Stage IIIB Rectal Cancer | Stage IIIC Rectal Cancer | Stage IIIA Colon Cancer | Stage IIIB Colon Cancer | Stage IIIC Colon Cancer | Recurrent Colon Cancer | Recurrent Rectal Cancer | Stage IVA Colon Cancer | Stage IVA Rectal Cancer and other conditionsUnited States
-
National Cancer Institute (NCI)Active, not recruitingMetastatic Rectal Adenocarcinoma | Rectal Adenocarcinoma | Stage III Rectal Cancer AJCC v7 | Stage IIIA Rectal Cancer AJCC v7 | Stage IIIB Rectal Cancer AJCC v7 | Stage IIIC Rectal Cancer AJCC v7 | Stage IV Rectal Cancer AJCC v7 | Stage IVA Rectal Cancer AJCC v7 | Stage IVB Rectal Cancer AJCC v7 | Locally...United States
-
City of Hope Medical CenterWithdrawnRecurrent Rectal Cancer | Stage I Rectal Cancer | Stage II Rectal Cancer | Stage III Rectal Cancer
Clinical Trials on Abdominoperineal extra-elevators rectal resection for low lying rectal cancer
-
Mansoura UniversityUniversity of Rome Tor VergataCompletedAnastomotic LeakageEgypt, Italy
-
Zagazig UniversityCompleted
-
Osama Mohammad Ali ElDamshetyMansoura University; Marche Polytechnic university, Ancona, ItalyCompleted
-
Radboud University Medical CenterAcademisch Medisch Centrum - Universiteit van Amsterdam (AMC-UvA)UnknownRectal Cancer | Anastomotic Leak Rectum
-
Changhai HospitalNot yet recruitingDepartment of Anorectal Surgery, Changhai Hospital Affiliated to Naval Medical University
-
Zagazig UniversityCompleted